Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-07

Clinical Trial Update: Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether rotigotine can enhance morphine analgesia in a dental postoperative pain model.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)

Snippet

Sponsor: East Carolina University | Conditions: Post-op Pain | Phase 2 | Status: UNKNOWN